Date Filed | Type | Description |
06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/08/2019 |
4
| Rasdal Andrew P (Exec Chairman of the Board) has filed a Form 4 on OBALON THERAPEUTICS INC
Txns:
| Bought 12,500 shares
@ $4, valued at
$50k
Bought 9,375 warrants
@ $4.4, valued at
$41.3k
|
|
03/13/2019 |
SC 13G/A
| Rasdal Andrew P reports a 4.6% stake in Obalon Therapeutics, Inc. |
01/04/2019 |
4
| Rasdal Andrew P (Exec Chairman of the Board) has filed a Form 4 on OBALON THERAPEUTICS INC
Txns:
| Granted 86,957 shares
@ $0 |
|
08/27/2018 |
4
| Rasdal Andrew P (CEO) has filed a Form 4 on OBALON THERAPEUTICS INC
Txns:
| Granted 109,890 shares
@ $1.82, valued at
$200k
|
|
05/02/2018 |
4
| Rasdal Andrew P (President & CEO) has filed a Form 4 on OBALON THERAPEUTICS INC
Txns:
| Granted 2,987 shares
@ $3.27, valued at
$9.8k
|
|
02/14/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/02/2017 |
4
| Rasdal Andrew P (President & CEO) has filed a Form 4 on OBALON THERAPEUTICS INC
Txns:
| Granted 808 shares
@ $7.17, valued at
$5.8k
|
|
05/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/05/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |